[Streptococcus gallolyticus infections in racing pigeons, a literature review].
S. gallolyticus, formerly known as S. bovis is known since 1988 as a facultative pathogen of racing pigeons. Important clinical signs include acute mortality, inability to fly, lameness, weight loss and slimy green diarrhea. A pathognomonic sign at post mortem examination is the presence of well circumscribed areas of necrosis in the pectoral muscle. Furthermore tenosynovitis of the supracoracoid muscle and arthritis of the knee, shoulder and hock can be observed. In one study S. gallolyticus septicaemia was diagnosed in 10% of necropsied pigeons. Since S. gallolyticus was also isolated from nearly 40% of clinical healthy pigeons it is regarded as a facultative pathogen. Various biotypes, serotypes and culture supernatant phenotypes can be distinguished. Supernatant phenotypes are identified on the basis of the presence of either a T1, T2 or T3 protein triplet and the presence or absence of an extracellular A protein. S. gallolyticus strains with A protein are highly virulent, while strains with only T3 or T2 protein are of moderately or low virulence respectively. Fimbriae are only seen in highly virulent and some of the moderately virulent strains. Possible virulence factors include survival in macrophages, adhesion to cells and toxin production. Infection with serotype 1 and 2 induces some degree of protection against re-infection with serotype 1, which offers perspectives for the development of a vaccine. Experimentally ampicillin, doxycycline and erythromycin have shown therapeutic effects. For the treatment of clinical cases the use of ampicillin is advocated, together with hygienic measures, such as the use of grid floors and avoiding overcrowding.
Afdeling Vogels en Bijzondere Dieren, Hoofdafdeling Geneeskunde van Gezelschapsdieren, Faculteit der Diergeneeskunde, Universiteit Utrecht, Yalelaan 8, 3584 CM Utrecht.
F
F
van der Toorn
J T
JT
Lumeij
D000667:Ampicillin / Q000627:therapeutic use; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D015373:Bacterial Typing Techniques / Q000662:veterinary; D001715:Bird Diseases / Q000382:microbiology* / Q000473:pathology / Q000628:therapy; D010856:Columbidae; D003937:Diagnosis, Differential; D004318:Doxycycline / Q000627:therapeutic use; D004917:Erythromycin / Q000627:therapeutic use; D006920:Hygiene; D009336:Necrosis; D010369:Pectoralis Muscles / Q000473:pathology; D010641:Phenotype; D013045:Species Specificity; D013290:Streptococcal Infections / Q000382:microbiology / Q000473:pathology / Q000628:therapy / Q000662:veterinary*; D013291:Streptococcus / Q000145:classification / Q000187:drug effects / Q000472:pathogenicity*; D014774:Virulence
D000900:Anti-Bacterial Agents; D004917:Erythromycin; D000667:Ampicillin; D004318:Doxycycline